10 domestic pharmaceutical companies won against the patent nullity trial of ‘Crestor’
10 domestic pharmaceutical companies won on the composite patent nullity trial of the hyperlipidemia treatment ‘Crestor’.
Thus, they have set a stable foundation to sell generic products of Crestor, which launched on the last April.
According to the pharmaceutical industry on the 26th, the Inte...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
